Relationship of 1 year hypokalemia incidence to clinical outcomes in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

被引：0
|
作者：
Alderman, Michael
Calhoun, David
Cushman, William
Davis, Barry
Eckfeldt, John
Einhorn, Paula
Ford, Charles
Franklin, Stanley
Furberg, Curt
Ong, Stephen
Oparil, Suzanne
Papademetriou, Vasilios
Piller, Linda
Probstfield, Jeffrey
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Univ Alabama, Birmingham, AL USA
[3] Memphis VAMC, Memphis, TN USA
[4] Univ Texas, Sch Publ Hlth, Houston, TX USA
[5] Univ Minnesota Hosp & Clin, Minneapolis, MN 55455 USA
[6] NHLBI, DHVD, Bethesda, MD 20892 USA
[7] Univ Calif Irvine, Los Angeles, CA USA
[8] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[9] Ong Med Ctr, Oxon Hill, MD USA
[10] VAMC Washington, Washington, DC USA
[11] Univ Washington, Seattle, WA 98195 USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：576 / 576
页数：1
相关论文
共 50 条
  • [1] The relation of hypokalemia at 1 year to morbidity and mortality: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) experience
    Alderman, M.
    Piller, L.
    Ford, C.
    Davis, B.
    Einhorn, P.
    Cushman, W.
    Calhoun, D.
    Eckfeldt, J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 671 - 671
  • [2] Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Piller, L
    Ford, C
    Davis, B
    Nwachuku, C
    Black, H
    Oparil, S
    Gappy, S
    Retta, T
    Probstfield, J
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 92A - 92A
  • [3] Results of clinical evidence - Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Lyakishev, AA
    KARDIOLOGIYA, 2003, 43 (04) : 61 - 62
  • [4] Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Practical implications
    Oparil, S
    HYPERTENSION, 2003, 41 (05) : 1006 - 1009
  • [5] Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results
    Davis, B
    Furberg, CD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 325 - 325
  • [6] Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, S
    Davis, BR
    Louis, GT
    Whelton, P
    Adrogue, H
    Egan, D
    Farber, M
    Payne, G
    Probstfield, J
    Ward, H
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 674 - 686
  • [7] The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Clinical center recruitment experience
    Wright, JT
    Cushman, WC
    Davis, BR
    Barzilay, J
    Colon, P
    Egan, D
    Lucente, T
    Nwachuku, C
    Pressel, S
    Leenen, FHH
    Frolkis, J
    Letterer, R
    Walsh, S
    Tobin, JN
    Deger, GE
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 659 - 673
  • [8] Clinical outcomes in participants with cardiovascular dysmetabolic syndrome in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Black, H
    Davis, B
    JOURNAL OF HYPERTENSION, 2005, 23 : S146 - S146
  • [9] Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
    Dhruva, Sanket S.
    Huang, Chenxi
    Spatz, Erica S.
    Coppi, Andreas C.
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Xu, Xiao
    Furberg, Curt D.
    Davis, Barry R.
    Pressel, Sara L.
    Coifman, Ronald R.
    Krumholz, Harlan M.
    HYPERTENSION, 2017, 70 (01) : 94 - 102
  • [10] Blood pressure control in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Cushman, WC
    Ford, CE
    Cutler, JA
    Margolis, KL
    Davis, BR
    Grimm, RH
    CIRCULATION, 2002, 106 (19) : 476 - 476
12345